Bleakley Financial Group
HCAT icon

Bleakley Financial Group’s Health Catalyst HCAT Stock Holding History

Bleakley Financial Group’s Portfolio HCAT Stock Details HCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-10,396
Closed -$105K – 962
2023
Q3 		$105K Sell
10,396
-407
-4% -$4.86K ﹤0.01% 831
2023
Q2 		$135K Sell
10,803
-681
-6% -$8.11K ﹤0.01% 861
2023
Q1 		$134K Buy
11,484
+10
+0.1% +$127 ﹤0.01% 842
2022
Q4 		$122K Buy
+11,474
New +$111K ﹤0.01% 818

Other funds holding HCAT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
DG
Daventry Group New York $133M AUM 32.28% 1-Year Est. Return
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bleakley Financial Group's HCAT Position: Q4 2023 in Review

Bleakley Financial Group sold out of Health Catalyst (HCAT) in Q4 2023, closing a stake of 10,396 shares — an estimated $105K sold.

Bleakley Financial Group first reported a position in HCAT in Q4 2022 and held it in 4 quarters. The position peaked at $135K in Q2 2023. 167 funds tracked by Wall St. Rank hold HCAT as of Q4 2023.

  • Bleakley Financial Group reported no remaining Health Catalyst position as of Q4 2023 after selling out during the quarter.
  • Bleakley Financial Group sold 10,396 Health Catalyst shares in Q4 2023, an estimated $105K.
  • Bleakley Financial Group first reported a position in Health Catalyst in Q4 2022 and held it in 4 quarters.
  • Bleakley Financial Group's Health Catalyst position peaked at $135K in Q2 2023.
  • 167 funds tracked by Wall St. Rank held Health Catalyst as of Q4 2023.

Based on Bleakley Financial Group's 13F filing for Q4 2023, filed 25 Jan 2024.